Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience


A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Articles from Mary Thompson:


Anaconda Biomed: A Whole-Clot Approach to Stroke Thrombectomy

Existing clot aspiration catheters for ischemic stroke have relatively small distal openings, which means the clot must be broken up and removed in pieces. That increases the risk of leaving embolic material behind and the need for multiple catheter passes to completely clear the vessel. Anaconda Biomed is tackling this issue with a system featuring a distal tip that expands to accommodate the full vessel diameter, thus enabling removal of the entire clot in a single piece.

Read Article